Fast-casual restaurant Dos Toros is one of the latest chains to go cash-free.
Marketing manager Marcus Byrd said that the change saved the team time and that most customers didn’t even notice a difference.
“We found that 85 percent of customers use cards already at Dos Toros,” he said in a Cheddar interview. “And of those 15 percent that use cash, we only found that one percent could not go to Dos Toros.”
The company first went cashless in October and other chains such as Sweetgreen have made similar changes. One recent study finds that nearly two-thirds of smartphone users dole out cash sometimes, they prefer to use cards or mobile payments. Research firm eMarketer credits speed and convenience, safety, and rewards for the change.
Still, going all digital does come with disadvantages. Power outages or WiFi issues mean payments can’t be processed. And the “unbanked” population -- the estimated 7 percent of U.S. households without a bank account are excluded.
Byrd says that the company is focused on bringing in those consumers.
“We’re actually going to come out with an app next year, and we hope that there’s a location that can accept cash and turn that into money on your app or on a gift card, so that everybody can enjoy Dos Toros,” he said.
For the full interview [click here](https://cheddar.com/videos/dos-toros-goes-cashless).
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
